Arvinas Inc (NASDAQ:ARVN)’s traded shares stood at 0.48 million during the latest session, with the company’s beta value hitting 2.25. At the last check today,
Viking Therapeutics Inc (NASDAQ:VKTX)’s traded shares stood at 0.6 million during the latest session, with the company’s beta value hitting 0.73. At the last check
Clover Health Investments Corp (NASDAQ:CLOV)’s traded shares stood at 0.51 million during the latest session, with the company’s beta value hitting 1.99. At the last
Absci Corp (NASDAQ:ABSI)’s traded shares stood at 1.05 million during the latest session, with the company’s beta value hitting 2.16. At the last check today,
ImmunityBio Inc (NASDAQ:IBRX)’s traded shares stood at 0.7 million during the latest session, with the company’s beta value hitting 0.44. At the last check today,
Designer Brands Inc (NYSE:DBI)’s traded shares stood at 0.83 million during the latest session, with the company’s beta value hitting 1.72. At the last check
Aspire Biopharma Holdings Inc (NASDAQ:ASBP)’s traded shares stood at 1.06 million during the latest session, with the company’s beta value hitting 0.76. At the last
Palantir Technologies Inc (NASDAQ:PLTR)’s traded shares stood at 28.6 million during the latest session, with the company’s beta value hitting 2.75. At the last check
Bitfarms Ltd (NASDAQ:BITF)’s traded shares stood at 5.91 million during the latest session, with the company’s beta value hitting 3.67.The BITF share’s 52-week high remains
Gevo Inc (NASDAQ:GEVO)’s traded shares stood at 0.63 million during the latest session, with the company’s beta value hitting 2.58. At the last check today,
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
